Mallinckrodt Pharmaceuticals
MNK
#10194
Rank
ยฃ3.5 M
Marketcap
ยฃ0.26
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Mallinckrodt Pharmaceuticals (MNK)

EPS in 2023 (TTM): -ยฃ99.61

According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ93.94. In 2021 the company made an earnings per share (EPS) of -ยฃ6.57 an increase over its 2020 EPS that were of -ยฃ8.68.

EPS history for Mallinckrodt Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ99.61
2021-ยฃ6.57-24.31%
2020-ยฃ8.68-5.41%
2019-ยฃ9.18-72.67%
2018-ยฃ33.59-291.46%
2017ยฃ17.54797.22%
2016ยฃ1.96-34.03%
2015ยฃ2.96-207.61%
2014-ยฃ2.75-366.73%
2013ยฃ1.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ยฃ10.93-111.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ1.55-98.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
ยฃ6.63-107.06%๐Ÿ‡บ๐Ÿ‡ธ USA